A group of researchers from the Peter MacCallum Cancer Centre, Melbourne, has been working on a project, which targets to kill cancerous blood cells.

Lead author Professor Grant McArthur said that they are at an initial stage of their study in which they have developed a treatment that will only kill cancerous blood cells, while healthy cells remain unaffected.

They will soon be initiating the clinical trials and their focus will be on lymphoma and leukaemia. Grant said that there was a reason to choose both the cancers, as till now both the types have been untouched in research field.

"Our initial studies have focused on cancers that are hard to treat, because it's a real unmet need there and patients with those cancers desperately need new treatments", further affirmed Grant. One of the biggest advantages of the development is that healthy cells remain unaffected.

During the research, the study researchers noticed that blood cancer cells have Achilles heel in their protein making factory. If protein synthesis is switched off in cancer cells, then treating the cancerous cells, is possible and that too without harming the healthy cells.

Grant said that they are probable chances that they would extend the treatment to other forms of cancer as well.